Pure profit of Ozon Pharmaceuticals for the first half of the year…
Pure profit of Ozon Pharmaceuticals for the first half of the year according to IFRS amounted to 3.2 billion rubles, which is 90% more than the same period last year.
Coverage (2 sources)
- Shareholders of Ozon Pharmaceuticals approved dividends for six months — Ведомости
- Ozon Pharmaceuticals approved dividends for the first half of 2026 — Коммерсантъ